SCHEMBL7505482

SCHEMBL7505482

COc1cccc(-c2cncc(-c3cn(CC(C)CN(C)C)c4cc(Cl)ccc34)c2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 3/20 0.54
▸ FLT1 P17948 1/20 0.54
▸ FLT4 P35916 1/20 0.54
▸ NR1D1 P20393 1/20 0.40
▸ AVPR1B P47901 1/20 0.35
▸ GSK3B P49841 2/20 0.35
▸ PRKCA P17252 1/20 0.35
▸ CYP11B1 P15538 2/20 0.34
▸ CYP11B2 P19099 2/20 0.34
▸ PRKACA P17612 1/20 0.34
▸ PRKACG P22612 1/20 0.34
▸ PRKACB P22694 1/20 0.34
▸ FNTA P49354 1/20 0.34
▸ FNTB P49356 1/20 0.34
▸ KCNH2 Q12809 2/20 0.34
▸ DYRK1A Q13627 1/20 0.34
▸ BRD4 O60885 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7552655 0.93 KDR (0.54) KDRFLT1FLT4NR1D1AVPR1B
SCHEMBL7508525 0.91 KDR (0.59) KDRFLT1FLT4NR1D1CYP11B1
SCHEMBL7547790 0.89 KDR (0.68) KDRFLT1FLT4NR1D1AVPR1B
SCHEMBL7990966 0.88 KDR (0.63) KDRFLT1FLT4NR1D1PRKACA
SCHEMBL7504838 0.88 KDR (0.54) KDRFLT1FLT4NR1D1CYP11B1
SCHEMBL7507277 0.87 KDR (0.58) KDRFLT1FLT4NR1D1AVPR1B
SCHEMBL7548685 0.86 KDR (0.60) KDRFLT1FLT4NR1D1PRKACA
SCHEMBL7552915 0.85 KDR (0.51) KDRFLT1FLT4NR1D1AVPR1B
SCHEMBL7991002 0.84 KDR (0.53) KDRFLT1FLT4GSK3BPRKCA
SCHEMBL7994231 0.83 KDR (0.70) KDRFLT1FLT4PRKCAPRKACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 — — EP claimed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 — — EP claimed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 — — WO claimed
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 — — EP disclosed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 — — EP disclosed
US-6265403-B1 TYROSINE INHIBITORS MERCK & CO., INC. 2001-07-24 — — US disclosed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 — — WO disclosed
Send feedback